{"DataElement":{"publicId":"13383451","version":"1","preferredName":"Therapeutic Procedure Cellular Immunotherapy Type","preferredDefinition":"The type of cellular immunotherapy.","longName":"13378555v1.00:13378761v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13378555","version":"1","preferredName":"Therapeutic Procedure Cellular Immunotherapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:The type of cellular immunotherapy.","longName":"2512834v1.00:13378554v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2512834","version":"1","preferredName":"Therapeutic Procedure","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B89860A-B9D6-3798-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"13378554","version":"1","preferredName":"Type of Cellular Immunotherapy","preferredDefinition":"The type of cellular immunotherapy.","longName":"C173289","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type of Cellular Immunotherapy","conceptCode":"C173289","definition":"The type of cellular immunotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9B20A24-9340-3B08-E053-731AD00ADE20","latestVersionIndicator":"Yes","beginDate":"2023-04-19","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-19","modifiedBy":"JKNABLE","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F9B20A24-9346-3B08-E053-731AD00ADE20","latestVersionIndicator":"Yes","beginDate":"2023-04-19","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-19","modifiedBy":"ZHWENDY","dateModified":"2023-04-24","changeDescription":null,"administrativeNotes":"4/24/2023: added Origin to DEC.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13378761","version":"1","preferredName":"Type of Cellular Immunotherapy Type","preferredDefinition":"The type of cellular immunotherapy._Something distinguishable as an identifiable class based on common qualities.","longName":"13378761v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Chimeric Antigen Receptor T-cell Therapy","valueDescription":null,"ValueMeaning":{"publicId":"7331413","version":"1","preferredName":"Chimeric Antigen Receptor T-Cell Therapy","longName":"7331413","preferredDefinition":"A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient's blood. Then the gene for a special receptor that binds to a certain protein on the patient's cancer cells is added in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. Chimeric antigen receptor T-cell therapy is being studied in the treatment of some types of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chimeric Antigen Receptor T-Cell Therapy","conceptCode":"C126102","definition":"Treatment that uses T-cells that have been engineered to contain a chimeric antigen receptor (CAR) that specifically targets a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D4A25B-396E-566A-E053-4EBD850AA9EA","latestVersionIndicator":"Yes","beginDate":"2020-06-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2020-06-11","modifiedBy":"KUMMEROA","dateModified":"2023-02-01","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B452ED-6FDC-2847-E053-731AD00A476B","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"},{"value":"Donor Lymphocyte Infusion","valueDescription":null,"ValueMeaning":{"publicId":"2866902","version":"1","preferredName":"Donor Leukocyte Infusion","longName":"2866902","preferredDefinition":"A type of therapy in which lymphocytes from the blood of a donor are given to a patient who has already received a stem cell transplant from the same donor. The donor lymphocytes may kill remaining cancer cells. Donor lymphocyte infusion is used to treat chronic myelogenous leukemia (CML) that has come back and myeloma. It is being studied in the treatment of other types of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Donor Lymphocyte Infusion","conceptCode":"C16145","definition":"The infusion of donor lymphocytes following hematopoietic stem cell transplantation for the purpose of augmenting the host immune response or preventing the rejection of the graft.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68DF7602-9A6D-3F9A-E040-BB89AD43599F","latestVersionIndicator":"Yes","beginDate":"2009-05-01","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-05-01","modifiedBy":"KUMMEROA","dateModified":"2022-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B452ED-6FDD-2847-E053-731AD00A476B","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B452ED-6FDE-2847-E053-731AD00A476B","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B452ED-6FDF-2847-E053-731AD00A476B","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9B452ED-6FE0-2847-E053-731AD00A476B","beginDate":"2023-04-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"13378760","version":"1","preferredName":"Type of Cellular Immunotherapy Type","preferredDefinition":"The type of cellular immunotherapy._Something distinguishable as an identifiable class based on common qualities.","longName":"13378760v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type of Cellular Immunotherapy","conceptCode":"C173289","definition":"The type of cellular immunotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9B3E7E7-791E-1791-E053-731AD00A4AF0","latestVersionIndicator":"Yes","beginDate":"2023-04-19","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-19","modifiedBy":"COLBERTM","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F9B3E7E7-791F-1791-E053-731AD00A4AF0","latestVersionIndicator":"Yes","beginDate":"2023-04-19","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-19","modifiedBy":"SOKKERL","dateModified":"2023-04-19","changeDescription":null,"administrativeNotes":"4/19 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173179","version":"1","longName":"Treatment","context":"Pediatric Cancer"},{"publicId":"12173206","version":"1","longName":"Cellular Immunotherapy","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"CIMT_TYPE","type":"PCDC Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"CIMT Type","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F9C68590-CE9D-60AD-E053-731AD00A8AA7","latestVersionIndicator":"Yes","beginDate":"2023-04-20","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-20","modifiedBy":"SOKKERL","dateModified":"2023-05-10","changeDescription":null,"administrativeNotes":"4/20/23 Curated for PCDC. BF","unresolvedIssues":null,"deletedIndicator":"No"}}